Linkedin Twitter Envelope

Irreversible electroporation in liver and pancreatic cancer

Home
Irreversible electroporation in liver and pancreatic cancer
Country
Agency
Year work was carried out
Linkk
Details of use
Austria
LBI-HTA
2019
–
National adaptation. Made no changes. Added executive summary in German.
Austria
GOEG
2019
–
Dissemination to MoH.
Italy
ASSR RER
2019
–
National adaptation. Added local information and budget impact / cost-effectiveness analysis.
Italy
AGENAS
2019
Ongoing
Translation of the report summary.
Slovakia
UNIBA
2019
–
National adaptation. Added local information and budget impact / cost-effectiveness analysis.
Spain
AVALIA
2019
–
National adaptation. Added local information.
Spain
SCS
2019
–
Assessment disseminated to clinicians.
United Kingdom (England)
NICE
2019
–
Read the assessment for background information. EUnetHTA assessments are included in NHS Evidence.
United Kingdom (Scotland)
SHTG
2019
–
Dissemination. Alerted clinicians in country working in this area. Included in regular ‘horizon scanning’ update sent to external stakeholders.

OUR NETWORK

CAREERS

HELP

eunethta@zinl.nl

CONTACT US

This website was produced under the Third EU Health Programme through a service contract with the European Health and Digital Executive Agency (HaDEA) acting under the mandate from the European Commission. The information and views set out in this website are those of the author(s) and do not necessarily reflect the official opinion of the Commission/Executive Agency. The Commission/Executive Agency do not guarantee the accuracy of the data included in this website. Neither the Commission/Executive Agency nor any person acting on the Commission’s/Executive Agency’s behalf may be held responsible for the use which may be made of the information contained therein.

©2021 EUnetHTA All rights reserved.

This website uses cookies to ensure you get the best experience on our website. By using the website you agree to our Privacy Policy and our Terms of Use.
Accept and Close